2024
Circulating long noncoding RNA: New frontiers in biomarker research for mood disorders
Roy B, Verma A, Hulwi E, Dwivedi Y. Circulating long noncoding RNA: New frontiers in biomarker research for mood disorders. 2024, 1-13. DOI: 10.61373/gp024i.0046.Peer-Reviewed Original ResearchMood disordersPathophysiology of mood disordersContext of mood disordersComplex psychiatric disorderSample of individualsDisease-specific contributionBipolar depressionPsychiatric disordersPredicting treatment responseMoodDisordersMental conditionTreatment responseBlood samples of individualsInvolvement of lncRNAsLong noncoding RNAsPeripheral blood samplesLncRNA researchLncRNAsMDDCognitionDepressionClinical studiesNoncoding RNAsIncreasing evidence
2023
Imaging biomarkers in the idiopathic inflammatory myopathies
Zubair A, Salam S, Dimachkie M, Machado P, Roy B. Imaging biomarkers in the idiopathic inflammatory myopathies. Frontiers In Neurology 2023, 14: 1146015. PMID: 37181575, PMCID: PMC10166883, DOI: 10.3389/fneur.2023.1146015.Peer-Reviewed Original ResearchIdiopathic inflammatory myopathiesManagement of IIMMagnetic resonance imagingElectrical impedance myographyPositron emission tomographyInflammatory myopathiesMuscle ultrasoundExtra-muscular manifestationsMuscle strength testingQuality of lifeObjective assessmentMuscle inflammationPatient managementTreatment responseBetter objective assessmentMuscle damageMuscle healthResonance imagingEmission tomographyClinical settingMuscle diseaseBiomarkersImpedance myographyMyopathyFurther validation
2020
Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study
Litchman T, Roy B, Kumar A, Sharma A, Njike V, Nowak RJ. Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study. Journal Of The Neurological Sciences 2020, 411: 116690. PMID: 32028072, DOI: 10.1016/j.jns.2020.116690.Peer-Reviewed Original ResearchConceptsMyasthenia gravisMGFA classRetrospective studyPositive myasthenia gravis patientsSingle-center retrospective studyManagement of MGAcetylcholine receptor autoantibodiesRefractory myasthenia gravisSymptom-free stateB-cell depletionMyasthenia gravis patientsClinical remissionClinical improvementDurable responsesMG patientsGravis patientsReceptor autoantibodiesMore hospitalizationsClinical symptomsExamination findingsCell depletionTreatment responsePatientsRituximabB cells